Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes

References

• GuanXLiYJiaoZCodelivery of antitumor drug and gene by a pH-sensitive charge-conversion systemACS Appl Mater Interfaces2015753207321525581567
   PubMed Web of Science ®Google Scholar
• SunTMDuJZYaoYDSimultaneous delivery of siRNA and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppressionACS Nano2011521483149421204585
   PubMed Web of Science ®Google Scholar
• WiradharmaNTongYWYangYYSelf-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effectBiomaterials200930173100310919342093
   PubMed Web of Science ®Google Scholar
• HanKChenSChenWHSynergistic gene and drug tumor therapy using a chimeric peptideBiomaterials201334194680468923537665
   PubMed Web of Science ®Google Scholar
• FergusonSMNortonCSWatsonSJAkilHRobinsonTEAmphetamine-evoked c-fos mRNA expression in the caudate-putamen: the effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental contextJ Neurochem2003861334412807422
   PubMed Web of Science ®Google Scholar
• PrimeauAJRendonAHedleyDLilgeLTannockIFThe distribution of the anticancer drug doxorubicin in relation to blood vessels in solid tumorsClin Cancer Res20051124 Pt 18782878816361566
   PubMed Web of Science ®Google Scholar
• CreixellMPeppasNACo-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistanceNano Today20127436737926257819
   PubMed Web of Science ®Google Scholar
• TsourisVJooMKKimSHKwonICWonYYNano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancersBiotechnol Adv20143251037105024924617
   PubMed Web of Science ®Google Scholar
• ChitkaraDSinghSMittalANanocarrier-based co-delivery of small molecules and siRNA/miRNA for treatment of cancerTher Deliv20167424525527010986
   PubMedGoogle Scholar
• LeeSYYangCYPengCLA theranostic micelleplex co-delivering SN-38 and VEGF siRNA for colorectal cancer therapyBiomaterials2016869210526896610
   PubMed Web of Science ®Google Scholar
• XiaoBMaLMerlinDNanoparticle-mediated co-delivery of chemotherapeutic agent and siRNA for combination cancer therapyExpert Opin Drug Deliv2017141657327337289
   PubMed Web of Science ®Google Scholar
• PeerDKarpJMHongSFarokhzadOCMargalitRLangerRNano-carriers as an emerging platform for cancer therapyNat Nanotechnol200721275176018654426
   PubMed Web of Science ®Google Scholar
• HuQSunWWangCGuZRecent advances of cocktail chemotherapy by combination drug delivery systemsAdv Drug Deliv Rev201698193426546751
   PubMed Web of Science ®Google Scholar
• Eldar-BoockAPolyakDScomparinASatchi-FainaroRNano-sized polymers and liposomes designed to deliver combination therapy for cancerCurr Opin Biotechnol201324468268923726153
   PubMed Web of Science ®Google Scholar
• SalzanoGCostaDFTorchilinVPsiRNA delivery by stimuli-sensitive nanocarriersCurr Pharm Des201521314566457326486143
   PubMed Web of Science ®Google Scholar
• ZaffaroniNDaidoneMGSurvivin expression and resistance to anticancer treatments: perspectives for new therapeutic interventionsDrug Resist Updat200252657212135582
   PubMed Web of Science ®Google Scholar
• CoumarMSTsaiFYKanwarJRSarvagallaSCheungCHTreat cancers by targeting survivin: just a dream or future reality?Cancer Treat Rev201339780281123453862
   PubMed Web of Science ®Google Scholar
• WangSHuangXLeeCKLiuBElevated expression of erbB3 confers paclitaxel resistance in erbB2-overexpressing breast cancer cells via upregulation of SurvivinOncogene201029294225423620498641
   PubMed Web of Science ®Google Scholar
• WangSHuangJLyuHTherapeutic targeting of erbB3 with MM-121/SAR256212 enhances antitumor activity of paclitaxel against erbB2-overexpressing breast cancerBreast Cancer Res2013155R10124168763
   PubMed Web of Science ®Google Scholar
• DingXWangWWangYVersatile reticular polyethylenimine derivative-mediated targeted drug and gene codelivery for tumor therapyMol Pharm201411103307332125058017
   PubMedGoogle Scholar
• LiuJJiangXXuLWangXHenninkWEZhuoRNovel reduction-responsive cross-linked polyethylenimine derivatives by click chemistry for nonviral gene deliveryBioconjug Chem201021101827183520828191
   PubMed Web of Science ®Google Scholar
• LimCYounYSLeeKSDevelopment of a robust pH-sensitive polyelectrolyte ionomer complex for anticancer nanocarriersInt J Nanomedicine20161170371326955270
   PubMed Web of Science ®Google Scholar
• SunTMDuJZYanLFMaoHQWangJSelf-assembled biodegradable micellar nanoparticles of amphiphilic and cationic block copolymer for siRNA deliveryBiomaterials200829324348435518715636
   PubMed Web of Science ®Google Scholar
• OhKTBronichTKBrombergLHattonTAKabanovAVBlock ionomer complexes as prospective nanocontainers for drug deliveryJ Control Release2006115191716919349
   PubMed Web of Science ®Google Scholar
• TranTHRamasamyTChoiJYTumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cellsInt J Nanomedicine2015105249526226346426
   PubMed Web of Science ®Google Scholar
• CaoNChengDZouSAiHGaoJShuaiXThe synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cellsBiomaterials20113282222223221186059
   PubMed Web of Science ®Google Scholar
• GuoSHuangLNanoparticles escaping RES and endosome: challenges for siRNA delivery for cancer therapyJ Nanomater20112011742895
   Web of Science ®Google Scholar
• HatakeyamaHAkitaHHarashimaHA multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemmaAdv Drug Deliv Rev201163315216020840859
   PubMed Web of Science ®Google Scholar
• RamasamyTHaidarZSTranTHLayer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugsActa Biomater201410125116512725169256
   PubMed Web of Science ®Google Scholar
• ShuaiXTMerdanTUngerFWittmarMKisselTNovel biodegradable ternary copolymers hy-PEI-g-PCL-b-PEG: synthesis, characterization, and potential as efficient nonviral gene delivery vectorsMacromolecules2003361557515759
   Web of Science ®Google Scholar
• KangLFanBSunPAn effective tumor-targeting strategy utilizing hypoxia-sensitive siRNA delivery system for improved anti-tumor outcomeActa Biomater20164434135427545812
   PubMed Web of Science ®Google Scholar
• ThambiTDeepaganVGYoonHYHypoxia-responsive polymeric nanoparticles for tumor-targeted drug deliveryBiomaterials20143551735174324290696
   PubMed Web of Science ®Google Scholar
• TangSYinQSuJInhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxelBiomaterials20154811525701027
   PubMed Web of Science ®Google Scholar
• NavarroGSawantRRBiswasSEssexSTros de IlarduyaCTorchilinVPP-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cellsNanomedicine (Lond)201271657822191778
   PubMed Web of Science ®Google Scholar
• MichaudLBValeroVHortobagyiGRisks and benefits of taxanes in breast and ovarian cancerDrug Saf200023540142811085347
   PubMed Web of Science ®Google Scholar
• LeeJLeeSCAcharyaGChangCJParkKHydrotropic solubilization of paclitaxel: analysis of chemical structures for hydrotropic propertyPharm Res20032071022103012880288
   PubMed Web of Science ®Google Scholar
• YinTWangLYinLZhouJHuoMCo-delivery of hydrophobic paclitaxel and hydrophilic AURKA specific siRNA by redox-sensitive micelles for effective treatment of breast cancerBiomaterials201561102525996409
   PubMed Web of Science ®Google Scholar
• ZhengCZhengMGongPPolypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapyBiomaterials201334133431343823375952
   PubMed Web of Science ®Google Scholar
• FengQYuMZWangJCSynergistic inhibition of breast cancer by co-delivery of VEGF siRNA and paclitaxel via vapreotide-modified core-shell nanoparticlesBiomaterials201435185028503824680191
   PubMed Web of Science ®Google Scholar
• TrielliMOAndreassenPRLacroixFBMargolisRLDifferential Taxol-dependent arrest of transformed and nontransformed cells in the G1 phase of the cell cycle, and specific-related mortality of transformed cellsJ Cell Biol199613536897008909543
   PubMed Web of Science ®Google Scholar
• KlibanovALMaruyamaKTorchilinVPHuangLAmphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Lett199026812352372384160
   PubMed Web of Science ®Google Scholar
• AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
   PubMed Web of Science ®Google Scholar
• MaedaHWuJSawaTMatsumuraYHoriKTumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJ Control Release2000651–227128410699287
   PubMed Web of Science ®Google Scholar
• JhaveriATorchilinVIntracellular delivery of nanocarriers and targeting to subcellular organellesExpert Opin Drug Deliv2016131497026358656
   PubMed Web of Science ®Google Scholar
• IshidaOMaruyamaKSasakiKIwatsuruMSize-dependent extravasation and interstitial localization of polyethyleneglycol liposomes in solid tumor-bearing miceInt J Pharm19991901495610528096
   PubMed Web of Science ®Google Scholar
• PetrosRADeSimoneJMStrategies in the design of nanoparticles for therapeutic applicationsNat Rev Drug Discov20109861562720616808
   PubMed Web of Science ®Google Scholar
• ZengQJiangHWangTZhangZGongTSunXCationic micelle delivery of Trp2 peptide for efficient lymphatic draining and enhanced cytotoxic T-lymphocyte responsesJ Control Release201520011225540903
   PubMed Web of Science ®Google Scholar
• RyanBMO’DonovanNDuffyMJSurvivin: a new target for anticancer therapyCancer Treat Rev200935755356219559538
   PubMed Web of Science ®Google Scholar
• DuffyMJO’DonovanNBrennanDJGallagherWMRyanBMSurvivin: a promising tumor biomarkerCancer Lett20072491496017275177
   PubMed Web of Science ®Google Scholar
• AltieriDCValidating survivin as a cancer therapeutic targetNat Rev Cancer200331465412509766
   PubMed Web of Science ®Google Scholar
• AmbrosiniGAdidaCAltieriDCA novel anti-apoptosis gene, survivin, expressed in cancer and lymphomaNat Med1997389179219256286
   PubMed Web of Science ®Google Scholar
• WangTHWangHSSoongYKPaclitaxel-induced cell death: where the cell cycle and apoptosis come togetherCancer200088112619262810861441
   PubMed Web of Science ®Google Scholar
• JordanMATosoRJThrowerDWilsonLMechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrationsProc Natl Acad Sci U S A19939020955295568105478
   PubMed Web of Science ®Google Scholar
• WangSZhuLZuoWMicroRNA-mediated epigenetic targeting of survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancerOncotarget2016725376933771327177222
   PubMedGoogle Scholar